Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
Sutherland
D E
DE
Department of Surgery, University of Minnesota, Minneapolis.
Moudry-Munns
K C
KC
Gruessner
A
A
D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology; D016035:Pancreas Transplantation / Q000276:immunology*; D011336:Probability; D012042:Registries; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D016572:Cyclosporine